Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease
- 259 Downloads
We reclassified the pathological subtypes of dementia with Lewy bodies (DLB), based on both Lewy pathology and Alzheimer pathology, to clarify the pathological entity of DLB and the boundary between DLB and Alzheimer’s disease (AD) in autopsied cases, using both pathological and immunohistochemical methods. DLB was classified as either limbic type or neocortical type according to the degree of Lewy pathology including Lewy bodies (LB) and LB-related neurites by our staging, and was classified as pure form, common form or AD form according to the degree of Alzheimer pathology including neurofibrillary tangles (NFT) and amyloid deposits by Braak staging. These combined subtypes were lined up on a spectrum, not only with Lewy pathology but also with other DLB-related pathologies including Alzheimer pathology, neuronal loss in the substantia nigra, spongiform change in the transentorhinal cortex and LB-related neurites in the CA2–3 region. In contrast, the Lewy pathology of AD did not meet the stages of Lewy pathology in DLB, and there were scarcely any similarities in other DLB-related pathologies between AD and DLB. In addition, the Lewy pathology of AD had characteristics different from that of DLB, including the coexistence rate of LB with NFT, and the immunohistochemical and immunoelectron microscopic findings of LB and LB-related neurites. These findings suggest that DLB is a distinctive pathological entity that can be differentiated from AD, although it shows some pathological subtypes.
KeywordsDementia with Lewy bodies Alzheimer’s disease Lewy pathology α-Synuclein Pathological subtypes
This research was supported by Grants-in-aid from the Japan Ministry of Education, Science, Sports and Culture, and from the Japan Ministry of Health, Labor and Welfare. We are grateful to Dr. T. Ishii for the generous supply of antibody.
- 2.Arima K, Mizutani T, Alim MA, Tonozuka-Uehara H, Izumiyama Y, Hirai S, Ueda K (2000) NACP/α-synuclein and tau constutute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies. Acta Neuropathol 100:115–121PubMedGoogle Scholar
- 6.Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer’s disease represents coexistence of Alzheimer disease and idiopathic Parkinson’s disease. J Neuropathol Exp Neurol 57:39–46Google Scholar
- 7.Del Tredici, Rüb U, Vos RAI de, Boel JRE, Braak H (2002) Where does Parkinson’s disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426Google Scholar
- 9.Hansen LA, Salmon D, Galasko D, Masliah E, Katzman R, De Teresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 40:1–8Google Scholar
- 11.Iseki E, Odawara T, Suzuki K, Kosaka K, Akiyama H, Ikeda K (1995) A pathological study of Lewy bodies and senile changes in the amygdala in diffuse Lewy body disease. Neuropathology 15:112–116Google Scholar
- 17.Kosaka K (1978) Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol (Berl) 42:127–134Google Scholar
- 19.Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathology 16:32–35Google Scholar
- 21.Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O’Connel B, Pollen DA, St George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ (1998) Lewy bodies contain alteredα-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365–1370PubMedGoogle Scholar
- 24.McKeith IG, Glasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Millar BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RAI de, Willcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB workshop. Neurology 47:1113–1124PubMedGoogle Scholar
- 25.Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standarization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedGoogle Scholar
- 26.Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer’s disease. J Neuropathol Exp Neurol 62:363–367Google Scholar